Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CYP-001 by Cynata Therapeutics for Respiratory Failure: Likelihood of Approval
CYP-001 is under clinical development by Cynata Therapeutics and currently in Phase I for Respiratory Failure. According to GlobalData, Phase...